Replies to post #3883 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

It surely sounds as though MNTA thinks that there may be many undisclosed applications already pending before the FDA.

I would respectfully submit that you misinterpreted Craig Wheeler’s remarks in a big way. It’s unlikely, IMO that there are several—or any—Paragraph-3 Lovenox ANDAs currently under review at the FDA, although it can’t be ruled out entirely.